Envoy Medical, Inc.
COCH- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001840877
No open-market purchases or sales by Envoy Medical, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.9M in total; no superinvestor holds it.
Other share classesCOCHW
Holders of 5% or more of COCH
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Envoy Medical, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Taylor Glen A | 13D/A | 84.80%68.9M shares | +40.60 ppfrom 44.20% | Dec 8, 20252 filings | Feb 17, 2026 | SEC |
| Anzu SPAC GP I LLC | 13D | 11.33%2.72M shares | New | Dec 26, 20241 filing | Dec 26, 2024 | SEC |
| Bleichroeder LP | 13G | 9.99%7.84M shares | New | May 14, 20261 filing | May 14, 2026 | SEC |
| Nantahala Capital Management, LLC | 13G | 9.99%7.68M shares | New | May 15, 20261 filing | May 15, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
14 Schedule 13D and 13G filings on Envoy Medical, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 15, 20264:41 PM ET | Nantahala Capital Management, LLCand 2 others | 13G | 9.99%7.68M shares | New | Mar 31, 2026 | SEC |
| May 14, 20266:01 PM ET | Bleichroeder LPand 2 others | 13G | 9.99%7.84M shares | New | Mar 31, 2026 | SEC |
| May 11, 20266:02 PM ET | Ayrton Capital LLCand 2 others | 13G/A | 3.10%2.46M shares | −4.77 ppfrom 7.87%Below 5% | Mar 31, 2026 | SEC |
| Feb 17, 20269:14 AM ET | Taylor Glen A | 13D/A | 84.80%68.9M shares | +40.60 ppfrom 44.20% | Feb 12, 2026 | SEC |
| Feb 11, 20269:38 AM ET | Ayrton Capital LLCand 2 others | 13G | 7.87%2.46M shares | New | Dec 31, 2025 | SEC |
| Dec 8, 20256:09 AM ET | Taylor Glen A | 13D | 44.20%14.7M shares | New | Dec 1, 2025 | SEC |
| Dec 26, 20246:46 PM ET | Anzu SPAC GP I LLCand 3 others | 13D | 11.33%2.72M shares | New | Sep 29, 2023 | SEC |
| Feb 12, 2024 | Aristeia Capital LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Glazer Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | Aristeia Capital LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Aristeia Capital LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Glazer Capital, LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Envoy Medical, Inc. shares.
No Form 144 notices for Envoy Medical, Inc. are on file.